Janneke M Brussee

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Randomized Controlled Trial

Pulmonary Arterial Hypertension

Preterm Infants

Top Venues

Journal of pharmacokinetics and pharmacodynamics

CPT: pharmacometrics & systems pharmacology

Antimicrobial agents and chemotherapy

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Janneke M Brussee, Patricia N Sidharta, Jasper Dingemanse, Andreas Krause
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Janneke M Brussee, Patricia N Sidharta, Jasper Dingemanse, Andreas Krause
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Janneke M Brussee, Patricia N Sidharta, Jasper Dingemanse, Andreas Krause
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension. Journal of pharmacokinetics and pharmacodynamics (2024)
Daniela Hofmann, Janneke M Brussee, Jessica D Schulz, Jean T Coulibaly, Marc Pfister, Jennifer Keiser
Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adults. The Journal of antimicrobial chemotherapy 77 (4) (2022)
Andreas Krause, Dominik Lott, Janneke M Brussee, Clemens Muehlan, Jasper Dingemanse
Population pharmacokinetic modeling of daridorexant, a novel dual orexin receptor antagonist. CPT: pharmacometrics & systems pharmacology (2022)
Janneke M Brussee, Noemi Hiroshige, Anna Neodo, Jean T Coulibaly, Marc Pfister, Jennifer Keiser
Population Pharmacokinetics and Exposure-Response Analysis of Tribendimidine To Improve Treatment for Children with Hookworm Infection. Antimicrobial agents and chemotherapy 65 (2) (2021)
Ines Mack, Mike Sharland, Janneke M Brussee, Sophia Rehm, Katharina M Rentsch, Julia Bielicki
Insufficient Stability of Clavulanic Acid in Widely Used Child-Appropriate Formulations. Antibiotics (Basel, Switzerland) 10 (2) (2021)
Janneke M Brussee, Anna Neodo, Jessica D Schulz, Jean T Coulibaly, Marc Pfister, Jennifer Keiser
Pharmacometric Analysis of Tribendimidine Monotherapy and Combination Therapies To Achieve High Cure Rates in Patients with Hookworm Infections. Antimicrobial agents and chemotherapy 65 (2) (2021)
Janneke M Brussee, Jessica D Schulz, Jean T Coulibaly, Jennifer Keiser, Marc Pfister
Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and Adults. Clinical pharmacology and therapeutics 106 (3) (2019)
Janneke M Brussee, Elke H J Krekels, Elisa A M Calvier, Semra Palić, Amin Rostami-Hodjegan, Meindert Danhof, Jeffrey S Barrett, Saskia N de Wildt, Catherijne A J Knibbe
A Pediatric Covariate Function for CYP3A-Mediated Midazolam Clearance Can Scale Clearance of Selected CYP3A Substrates in Children. The AAPS journal 21 (5) (2019)
Janneke M Brussee, Huixin Yu, Elke H J Krekels, Berend de Roos, Margreke J E Brill, Johannes N van den Anker, Amin Rostami-Hodjegan, Saskia N de Wildt, Catherijne A J Knibbe
First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates. CPT: pharmacometrics & systems pharmacology 7 (6) (2018)
Janneke M Brussee, Nienke J Vet, Elke H J Krekels, Abraham J Valkenburg, Évelyne M Jacqz-Aigrain, Joop M A van Gerven, Eleonora L Swart, Johannes N van den Anker, Dick Tibboel, Matthijs de Hoog, Saskia N de Wildt, Catherijne A J Knibbe
Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure. British journal of clinical pharmacology 84 (2) (2017)